WallStreetZenWallStreetZen

NASDAQ: HALO
Halozyme Therapeutics Inc Stock Ownership - Who owns Halozyme Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Halozyme Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-04-1710,000$38.49
$384.89kSell
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-04-1710,000$8.11
$81.10kBuy
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-04-1610,000$8.11
$81.10kBuy
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-04-1610,000$38.35
$383.50kSell
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-03-262,890$8.11
$23.44kBuy
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-03-26292$16.78
$4.90kBuy
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-03-268,436$12.07
$101.82kBuy
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-03-1310,000$42.27
$422.73kSell
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-03-133,551$8.11
$28.80kBuy
Michael J. LabarreSVP CHIEF TECHNICAL OFFICER2024-03-136,449$12.07
$77.84kBuy

1 of 9

HALO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HALO insiders and whales buy or sell their stock.

HALO Shareholders

What type of owners hold Halozyme Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk21.00%26,633,924$1.03BInsider
Blackrock Inc14.69%18,630,963$718.60MInstitution
Vanguard Group Inc10.45%13,259,514$511.42MInstitution
Artisan Partners Limited Partnership5.27%6,689,058$258.00MInstitution
State Street Corp5.11%6,475,549$249.76MInstitution
Snyder Capital Management L P2.92%3,709,599$143.08MInstitution
Gregory Ian Frost2.87%3,641,380$140.45MInsider
Alliancebernstein LP2.73%3,463,694$133.59MInstitution
Macquarie Group Ltd2.59%3,282,640$126.61MInstitution
Jpmorgan Chase Co2.44%3,093,932$119.33MInstitution

1 of 3

HALO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HALO78.23%21.77%Net SellingNet Selling
IBRX8.50%7.94%Net BuyingNet Selling
KRYS75.55%24.45%Net SellingNet Selling
BBIO55.86%44.14%Net SellingNet Selling
CRSP62.44%37.56%Net BuyingNet Buying
View Top Biotech Stocks

Halozyme Therapeutics Stock Ownership FAQ

Who owns Halozyme Therapeutics?

Halozyme Therapeutics (NASDAQ: HALO) is owned by 97.89% institutional shareholders, 27.24% Halozyme Therapeutics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Halozyme Therapeutics shareholder, owning 26.63M shares representing 21.00% of the company. Randal J. Kirk's Halozyme Therapeutics shares are currently valued at $1.03B.

If you're new to stock investing, here's how to buy Halozyme Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.